Pegcetacoplan - Apellis Pharmaceuticals/Swedish Orphan Biovitrum
At a glance
- Drug Originator Apellis Pharmaceuticals
- Drug Licenced by Pint Pharma; Swedish Orphan Biovitrum
- Drug Class Anti-inflammatories; Anti-ischaemics; Antianaemics; Antithrombotics; Cyclic peptides; Eye disorder therapies; Polyethylene glycols; Urologics
- Mechanism of Action Complement C3 inhibitors
- USA Patent Applicants APELLIS PHARMS
- USA Patents 19
- NDAs 2
- International Patents 201
Table of Contents
Disclaimer